Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heike Lüders

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Translational Pediatrics|February 3, 2016
Treatment of Hodgkin's lymphoma in childhood and adolescence without radiotherapyWolfgang Dörffel, Alexander Claviez, Heike Lüders, et al.
Deutsches Arzteblatt International|June 4, 2015
Secondary Malignancies Following Treatment for Hodgkin's Lymphoma in Childhood and AdolescenceWolfgang Dörffel, Marianne Riepenhausenl, Heike Lüders, et al.
BMC Pulmonary Medicine|August 31, 2013
A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptanClaudia Petereit, Okan Zaba, Ishak Teber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Reply to A.S. ReeseWolfgang Dörffel, Heike Lüders, Alexander Claviez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2005
Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphomaAlexander Claviez, Markus Tiemann, Heike Lüders, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 2, 2005
Proliferation characteristics in pediatric Hodgkin's lymphoma point to a cell cycle arrest in the G(1) phaseMarkus Tiemann, Alexander Claviez, Heike Lüders, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 2013
The impact of central review and central therapy planning on the treatment of children and adolescents with Hodgkin lymphomaHeike Lüders, Ursula Rühl, Heinz Marciniak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study groupGünther Schellong, Wolfgang Dörffel, Alexander Claviez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2013
Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95Wolfgang Dörffel, Ursula Rühl, Heike Lüders, et al.
Translational Lung Cancer Research|March 15, 2021
KRAS<sup>G12C</sup>/TP53 co-mutations identify long-term responders to first line palliative treatment with pembrolizumab monotherapy in PD-L1 high (≥50%) lung adenocarcinomaNikolaj Frost, Jens Kollmeier, Claudia Vollbrecht, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Translational Pediatrics|February 3, 2016
Treatment of Hodgkin's lymphoma in childhood and adolescence without radiotherapyWolfgang Dörffel, Alexander Claviez, Heike Lüders, et al.
Deutsches Arzteblatt International|June 4, 2015
Secondary Malignancies Following Treatment for Hodgkin's Lymphoma in Childhood and AdolescenceWolfgang Dörffel, Marianne Riepenhausenl, Heike Lüders, et al.
BMC Pulmonary Medicine|August 31, 2013
A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptanClaudia Petereit, Okan Zaba, Ishak Teber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Reply to A.S. ReeseWolfgang Dörffel, Heike Lüders, Alexander Claviez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2005
Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphomaAlexander Claviez, Markus Tiemann, Heike Lüders, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 2, 2005
Proliferation characteristics in pediatric Hodgkin's lymphoma point to a cell cycle arrest in the G(1) phaseMarkus Tiemann, Alexander Claviez, Heike Lüders, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 2013
The impact of central review and central therapy planning on the treatment of children and adolescents with Hodgkin lymphomaHeike Lüders, Ursula Rühl, Heinz Marciniak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study groupGünther Schellong, Wolfgang Dörffel, Alexander Claviez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2013
Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95Wolfgang Dörffel, Ursula Rühl, Heike Lüders, et al.
Translational Lung Cancer Research|March 15, 2021
KRAS<sup>G12C</sup>/TP53 co-mutations identify long-term responders to first line palliative treatment with pembrolizumab monotherapy in PD-L1 high (≥50%) lung adenocarcinomaNikolaj Frost, Jens Kollmeier, Claudia Vollbrecht, et al.
Pageof 2